Your trusted source for investing success
By Shelly Kumar
ABcann Global Corporation (TSX-V:ABCN) (“ABcann” or the “Company”) is pleased to announce that it has received total proceeds of $11,895,298 from the exercise of an aggregate of 19,185,965 warrants since the closing of the Company’s acquisition of ABcann Medicinals Inc. (“ABcann Medicinals”) on April 28, 2017. These warrants, each of which
The Investing News rounds some of the biggest news in the cannabis market for the past trading week
By Jocelyn Aspa
The Canadian marijuana sector is one of the hottest growing sectors. Here’s a look at Canadian cannabis companies for investors to consider.
The Investing News reported took a closer look at some of the big cannabis news of the week and published an interview with the president of Cannabis Wheaton.
By Shelly Kumar
ABcann Global Corporation (TSX-V:ABCN) (“ABcann” or the “Company”) is pleased to release the Company’s financial results for the three and six months ended June 30, 2017. Copies of the interim filings, including the Management’s Discussion and Analysis, are available on the Company’s website and under the Company’s SEDAR profile at www.sedar.com.
The first half
By Shelly Kumar
ABcann Global Corporation (TSXV:ABCN) is pleased to announce the release of one of Canada’s highest legal CBD:THC (cannabidol:tetrahydrocannabinol) ratio products available on the market by its wholly-owned subsidiary, ABcann Medicinals Inc.
The release of CBD-Med is part of the Company’s strategy to provide a diverse range of products as it formally initiates
INN talks with the director of one of the most interesting proposals in the Canadian cannabis market.
This past trading in the cannabis marketplace saw another major dip to the Marijuana Life Sciences Index, the first medical marijuana study funded by a US medical government research group.
From Canadian LPs banding together asking for tougher promotional regulations to the acquisition of ABcann by Cannabis Wheaton and a variety of market news INN provides a roundup of the week in cannabis.
By Shelly Kumar
ABcann Global Corporation (TSXV:ABCN) and Cannabis Wheaton Income Corp. (TSX.V:CBW) (“Cannabis Wheaton” or “CW”) are pleased to announce completion of CW’s purchase of $15 million of ABcann common shares at an agreed upon valuation of $2.25 per share (the “Initial Investment”). The Initial Investment forms part of a larger phased investment by Cannabis
By Shelly Kumar
ABcann Global Corporation (TSXV:ABCN) and Cannabis Wheaton Income Corp. (TSX.V:CBW) (“Cannabis Wheaton” or “CW”) is pleased to provide an update on the Company’s construction and expansion timelines for its Vanluven and Kimmett facilities, both located in Napanee, Ontario.
ABcann confirms that plans to commence construction at the Company’s Kimmett facility in Q3 2017 remain
By Shelly Kumar
ABcann Global Corporation (TSXV:ABCN) and Cannabis Wheaton Income Corp. (TSX.V:CBW) (“Cannabis Wheaton” or “CW”) are pleased to report that they have entered into a binding interim agreement (the “Agreement”) to fund the construction of 50,000 square feet of cultivation space (the “Expansion Production Area”) at ABcann’s proposed cannabis cultivation facility
The marijuana sector in Canada is heating up, and publicly traded cannabis companies are performing well since entering the scene. Here’s a brief overview of some of the top gainers.
By Pia Rivera
ABcann Global Corporation (TSXV:ABCN) (the “Company”) is pleased to announce the appointment of W. Brett Wilson to the Advisory Board of the Company
By Shelly Kumar
ABcann Global (TSX-V:ABCN) (formerly Panda Capital Inc.) (“ABcann” or the “Company”) is pleased to announce that it has completed its Qualifying Transaction (as defined in the policies of the TSX Venture Exchange (the “TSXV”)) (the “Transaction”), pursuant to which it acquired all of the outstanding securities of ABcann Medicinals Inc. (“ABcann
Cronos Group provided an update to investors about its cannabis investments.
By Shelly Kumar
Panda Capital Inc. (TSX-V: PDA.H) (“Panda”) is pleased to announce that it has entered into a definitive amalgamation agreement dated effective November 30, 2016 (the “Amalgamation Agreement”) with ABcann Medicinals Inc. (“ABcann”), an arm’s length Ontario-based licensed producer of medical cannabis, pursuant to which Panda has agreed to acquire all
